PLK1 and esophageal squamous cell carcinoma: Wu et al. reported that combined treatment with the PLK1 inhibitor BI2536 and DDP at low doses induced pyroptosis via the caspase-3/GSDME axis in esophageal squamous cell carcinoma (Wu et al., 2019).